Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 15 studies | 45% ± 17% | |
CD16-positive, CD56-dim natural killer cell, human | 6 studies | 21% ± 6% | |
natural killer cell | 5 studies | 20% ± 4% | |
endothelial cell of lymphatic vessel | 5 studies | 24% ± 4% | |
oligodendrocyte precursor cell | 5 studies | 25% ± 7% | |
endothelial cell | 4 studies | 26% ± 6% | |
astrocyte | 3 studies | 31% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 29% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 97% | 702.26 | 2571 / 2642 | 98% | 11.77 | 692 / 705 |
ovary | 99% | 1748.09 | 179 / 180 | 95% | 7.67 | 408 / 430 |
lung | 100% | 1283.13 | 577 / 578 | 93% | 9.23 | 1074 / 1155 |
breast | 97% | 394.07 | 447 / 459 | 91% | 5.93 | 1022 / 1118 |
uterus | 100% | 495.19 | 170 / 170 | 83% | 7.77 | 381 / 459 |
kidney | 99% | 515.78 | 88 / 89 | 76% | 5.71 | 682 / 901 |
intestine | 79% | 1718.76 | 761 / 966 | 95% | 18.98 | 502 / 527 |
thymus | 99% | 470.42 | 648 / 653 | 59% | 3.60 | 359 / 605 |
bladder | 86% | 436.62 | 18 / 21 | 69% | 8.75 | 346 / 504 |
stomach | 54% | 109.91 | 194 / 359 | 93% | 13.89 | 267 / 286 |
skin | 81% | 334.97 | 1470 / 1809 | 62% | 3.20 | 293 / 472 |
esophagus | 52% | 108.20 | 749 / 1445 | 80% | 6.97 | 147 / 183 |
prostate | 97% | 367.03 | 237 / 245 | 32% | 0.96 | 163 / 502 |
pancreas | 28% | 62.77 | 93 / 328 | 93% | 10.47 | 165 / 178 |
adrenal gland | 79% | 210.74 | 203 / 258 | 22% | 0.85 | 50 / 230 |
spleen | 100% | 4934.80 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 446.79 | 1171 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 10.59 | 40 / 45 |
peripheral blood | 74% | 682.73 | 687 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 5.27 | 21 / 29 |
liver | 35% | 63.53 | 79 / 226 | 30% | 2.41 | 120 / 406 |
blood vessel | 60% | 185.08 | 807 / 1335 | 0% | 0 | 0 / 0 |
heart | 47% | 113.66 | 405 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 0.59 | 13 / 80 |
muscle | 6% | 9.17 | 45 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010762 | Biological process | regulation of fibroblast migration |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0090316 | Biological process | positive regulation of intracellular protein transport |
GO_0061014 | Biological process | positive regulation of mRNA catabolic process |
GO_0038203 | Biological process | TORC2 signaling |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0031932 | Cellular component | TORC2 complex |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PRR5L |
Protein name | Proline-rich protein 5-like (Protein observed with Rictor-2) (Protor-2) Proline rich 5 like |
Synonyms | PROTOR2 |
Description | FUNCTION: Associates with the mTORC2 complex that regulates cellular processes including survival and organization of the cytoskeleton . Regulates the activity of the mTORC2 complex in a substrate-specific manner preventing for instance the specific phosphorylation of PKCs and thereby controlling cell migration . Plays a role in the stimulation of ZFP36-mediated mRNA decay of several ZFP36-associated mRNAs, such as TNF-alpha and GM-CSF, in response to stress . Required for ZFP36 localization to cytoplasmic stress granule (SG) and P-body (PB) in response to stress . . |
Accessions | ENST00000527487.1 [Q6MZQ0-4] ENST00000527172.5 E9PS02 ENST00000526728.5 ENST00000524380.5 Q6MZQ0 ENST00000530252.1 E9PP62 ENST00000530050.5 ENST00000526679.1 E9PJV4 E9PL62 ENST00000378867.7 [Q6MZQ0-1] E9PIU0 ENST00000526682.5 ENST00000532121.5 E9PP25 ENST00000530639.6 [Q6MZQ0-1] E9PLJ6 |